Back to top
more

Endologix, Inc. (ELGX)

(Delayed Data from NSDQ)

$6.50 USD

6.50
664,018

+0.18 (2.85%)

Updated May 3, 2019 04:00 PM ET

After-Market: $6.51 (%) 5:22 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy23.68%
2Buy17.55%
3Hold9.21%
4Sell4.93%
5Strong Sell2.36%
S&P50010.96%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

NA Value NA Growth NA Momentum NA VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

NA

Industry: NA

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Better trading starts here.

Zacks News

Endologix (ELGX) Reports Q1 Loss, Tops Revenue Estimates

by Zacks Equity Research

Endologix (ELGX) delivered earnings and revenue surprises of -19.40% and 0.04%, respectively, for the quarter ended March 2020. Do the numbers hold clues to what lies ahead for the stock?

SmileDirectClub (SDC) Catches Eye: Stock Jumps 13.3%

by Zacks Equity Research

SmileDirectClub (SDC) saw a big move last session, as its shares jumped more than 13% on the day, amid huge volumes.

Is the Options Market Predicting a Spike in Endologix (ELGX) Stock?

by Zacks Equity Research

Investors need to pay close attention to Endologix (ELGX) stock based on the movements in the options market lately.

Endologix (ELGX) Reports Q3 Loss, Tops Revenue Estimates

by Zacks Equity Research

Endologix (ELGX) delivered earnings and revenue surprises of 15.63% and 1.46%, respectively, for the quarter ended September 2019. Do the numbers hold clues to what lies ahead for the stock?

Endologix (ELGX) Expected to Beat Earnings Estimates: Should You Buy?

by Zacks Equity Research

Endologix (ELGX) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Endologix (ELGX) Reports Q2 Loss, Tops Revenue Estimates

by Zacks Equity Research

Endologix (ELGX) delivered earnings and revenue surprises of 53.75% and 0.41%, respectively, for the quarter ended June 2019. Do the numbers hold clues to what lies ahead for the stock?

Will Endologix (ELGX) Report Negative Earnings Next Week? What You Should Know

by Zacks Equity Research

Endologix (ELGX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Endologix, Inc. (ELGX) Shares March Higher, Can It Continue?

by Zacks Equity Research

As of late, it has definitely been a great time to be an investor in Endologix, Inc. (ELGX).

Zacks.com featured highlights include: Avis, California Resources, Brinker, Endologix and Brookdale

by Zacks Equity Research

Zacks.com featured highlights include: Avis, California Resources, Brinker, Endologix and Brookdale

Maharathi Basu headshot

5 Broker-Friendly Stocks to Combat Market Jitters

by Maharathi Basu

In view of the ongoing uncertainties it is in the best interest of investors to seek guidance from brokers for designing a winning portfolio of stocks.

Endologix (ELGX) Reports Q1 Loss, Tops Revenue Estimates

by Zacks Equity Research

Endologix (ELGX) delivered earnings and revenue surprises of 28.21% and 4.19%, respectively, for the quarter ended March 2019. Do the numbers hold clues to what lies ahead for the stock?

Will Endologix (ELGX) Report Negative Earnings Next Week? What You Should Know

by Zacks Equity Research

Endologix (ELGX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Endologix (ELGX) Upgraded to Strong Buy: Here's Why

by Zacks Equity Research

Endologix (ELGX) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

All You Need to Know About Endologix (ELGX) Rating Upgrade to Buy

by Zacks Equity Research

Endologix (ELGX) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

Endologix (ELGX) Expected to Beat Earnings Estimates: Can the Stock Move Higher?

by Zacks Equity Research

Endologix (ELGX) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

WellCare Health (WCG) Q4 Earnings Beat Estimates, Soar Y/Y

by Zacks Equity Research

WellCare Health's (WCG) Q4 earnings gain from Meridian buyout and growth in membership.

Humana's (HUM) Q4 Earnings Surpass Estimates, Improve Y/Y

by Zacks Equity Research

Humana's (HUM) fourth-quarter earnings gain on the back of Medicare Advantage membership growth and operating efficiencies.

Centene's (CNC) Earnings Top Estimates in Q4, Surge Y/Y

by Zacks Equity Research

Centene's (CNC) Q4 earnings ride high on robust revenues, solid acquisitions and stronger Health Insurance Marketplace business.

Endologix (ELGX) Reports Q3 Loss, Tops Revenue Estimates

by Zacks Equity Research

Endologix (ELGX) delivered earnings and revenue surprises of 40.00% and 9.30%, respectively, for the quarter ended September 2018. Do the numbers hold clues to what lies ahead for the stock?

Endologix (ELGX) Q3 Earnings Preview: What's Shaping Up?

by Zacks Equity Research

Endologix (ELGX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Endologix (ELGX) Reports Q2 Loss, Tops Revenue Estimates

by Zacks Equity Research

Endologix (ELGX) delivered earnings and revenue surprises of 5.26% and 0.88%, respectively, for the quarter ended June 2018. Do the numbers hold clues to what lies ahead for the stock?

    3 Dental Stocks to Top Earnings Estimates This Season

    by Zacks Equity Research

    On upbeat consumer sentiment and increased business investments, the dental supplies industry appears to be in the pink of health now.

      Implied Volatility Surging for Endologix (ELGX) Stock Options

      by Zacks Equity Research

      Endologix (ELGX) warrants investors' attention based on moves in the options market lately.